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Angiotensin 11: Renal localization in glomerular mesangial cells by
autoradiography. The intrarenal localization of 'H-angiotensin II
after intraaortic administration in anesthetized rats has been
studied by autoradiography. A net concentration of radioactivity is
seen in the glomeruli as compared with tubules, blood vessels and
interstices. Within the glomerulus this radioactivity is
predominantly localized in the mesangial cells. This mesangial con-
centration of radioactivity is present at 1, 2 and 5 mm after 3H-
angiotensin administration but is considerably diminished after 30
mm. Administration of a large dose of angiotensin II or of lIe'-
angiotensin II (a competitive inhibitor of angiotensin II) with the
'H-angiotensin II prevented the mesangial concentration of
radioactivity. A similar dose of noradrenaline did not have this
effect. 'H-2-8-angiotensin Il-heptapeptide also showed a mesangial
distribution, whereas 'H-tyrosine did not. Less mesangial radioac-
tivity after 'H-angiotensin administration was seen in rats kept on
a low salt diet for four days than in those receiving a high salt diet.
The possibility of an action of angiotensin II at the level of the
mesangial cells is discussed.
Angiotensine II: Localisation rénale dans les cellules mesangiales
du glomerule demontrée par autoradiographie. La localisation in-
trarénale de l'angiotensine tritiée après son administration par voie
intra-aortique chez le rat anesthésié, a été étudiée par radio-
autographie. Une nette concentration de Ia radioactivité dans les
glomérules par rapport aux tubes, intestins et vaisseaux sanguins
est observée. A I'intérieur du glomérule, cette radioactivité est
localisé presque exclusivement dans les cellules mésangiales. Cet-
te concentration mésangiale de Ia radioactivité existe a 1 mm, 2
mm et 5 mm aprés l'administration de 'H-angiotensine II, mais die
est considérablement attónuée au bout de 30 mm. L'administration
d'une forte dose d'angiotensine II ou de lle'-angiotensine II (un in-
hibiteur compétitif de l'angiotensine II) avec Ia 'H-angiotensine II
supprime cette concentration mésangiale de Ia radioactivité. Une
dose égale de noradrénaline n'a pas cet efl'et suppresseur. Le 3H-2-
8-angiotensine II heptapeptide se concentre également dans les ccl-
lules mésangiales, mais pas Ia 3H-tyrosine. La radioactivité més-
angiale est moms forte chez les rats soumis a un régime pauvre en
sd pendant 4 jours que chez les rats ayant un régime riche en sd.
La possibilité d'une action de l'angiotensine II au niveau des ccl-
lules mésangiales est discutée.
The role of angiotensin II within the kidney re-
mains unclear. This hormone can cause either an in-
crease or a decrease in the renal excretion of sodium
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and water depending on the dose, the route of ad-
ministration, the species and the physiological state
of the animal (for reviews see [1,2]). In a previous
study we found that after an intraaortic injection of
3H-angiotensin II, radioactivity rapidly concentrates
in the kidney, where after two minutes it was almost
three times higher than in plasma [3]. This
phenomenon fits well with the concept that the
kidney is a target organ for angiotensin II, but it does
not give any indication as to the site of action of the
hormone. Angiotensin II may have two possible sites
of action within the kidney. Although many of its
effects may be explained by its vasoconstrictor action
on the different components of the renal vasculature,
a direct tubular effect has also been suggested by ex-
periments of Vander [4], Langford [5] and Leyssac[6]. In addition, since there is evidence that
angiotensin II may be produced in situ, close to the
site of renin production, Thurau has postulated that
angiotensin II may be involved in the control of
glomerular filtration rate at the level of a single
nephron [7]. It is thus of interest to know where in the
kidney angiotensin II is localized after its administra-
tion. Having at our disposal a tritiated angiotensin H
of high specific activity and intact biological activity,
we have been able to perform the following
autoradiographic study on the intrarenal localization
of angiotensin II. Unexpectedly, no appreciable
radioactivity was found either in the renal arterioles
or tubules, but net concentration was noted in the
glomerular mesangial cells. This mesangial reaction
appears to be specific for angiotensin II.
Methods
Radioactive compounds. 1) A sn'-3H- Tyr4- Val'-
angiotensin II was supplied by the Centre d' Energie
Atomique, Saclay. It is produced by catalytic
dehalogenation of iodinated angiotensin II in an at-
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mosphere of tritium, the molecule being labelled only
on the tyrosine residue. It has a specific activity rang-
ing from 30 to 56 Ci/mmole and a biological activity
of 100% of that of the unlabelled hormone [8]. Before
each experiment, the absence of degradation
products in the 3H-angiotensin II was checked by
comparing the protein content and biological activity
of the tritiated hormone with that of the unlabelled
hormone. In addition, thin-layer chromatography
was performed on the tritiated angiotensin II, the
presence of a single peak indicating absence of
products of degradation.
2) 3H-2-8-angiotensin JI-heptapeptide, the unla-
belled heptapeptide, synthesized and donated by F. M.
Bumpus (Research Division, Cleveland Clinic,
Cleveland, Ohio, U.S.A.) was tritiated by the same
process as the angiotensin II. This heptapeptide,
which is produced in vivo by aminopeptidase action
on angiotensin II, possessed in our experiments 60%
of the biological activity of angiotensin II in the rat
blood pressure preparation.
3) 3H-tyrosine was supplied by the Radiochemical
Centre, Amersham and used directly on arrival. Its
specific activity was 30 Ci/mmole.
Preparation of animals. Renal autoradiographs
were performed on 42 male Sprague-Dawley rats of
300 20 g of body wt. All were fed normal labora-
tory chow unless otherwise specified. They were
anesthetized i.p. with sodium pentobarbital (Nem-
butal, Abbott), 40 mg/kg. After laparotomy and
deflection of the gut, a first cannula (PE 100) was in-
troduced into the lower aorta, towards the heart, its
tip remaining well below the renal arteries. A ligature
was positioned, but not tied, around the aorta above
the origin of the right renal artery and a second can-
nula (PE 10) was inserted into the left carotid artery
against the flow, its tip just entering the aorta. All
radioactive and other compounds were administered
as bolus injections into the aorta via the carotid can-
nula.
Method of fixation. At the required time after the
injection of radioactive compounds, the ligature
around the mid-aorta was tightened, an incision
made in the inferior vena cava and 15 to 20 ml of
glutaraldehyde at 2.3% in 45 m sodium cacodylate
solution was perfused into the kidneys via the aortic
cannula. The kidneys were then excised and small
fragments of cortex were further fixed in
glutaraldehyde for 45 mm.
That the radioactivity remaining in the tissue after
such fixation was predominantly bound to the tissue
was suggested by experiments in which whole tissue
radioactivity was compared in fixed kidneys after ad-
ministration of 3H-angiotensin or 3H-inulin, the latter
serving as a marker of extracellular space. After 3H-
angiotensin administration, 30 to 50% of the total
renal radioactivity remained after fixation, whereas
after administration of 8sg of 3H-inulin (specific ac-
tivity, 0.14 Ci/g; C.E.A. Saclay) and identical fixa-
tion, less than 10% of the radioactivity remained, sug-
gesting that the fixing procedure removed essentially
extracellular radioactivity.
Embedding and preparation of autoradiographs.
After a 30-sec rinse in 150 m sodium cacodylate
solution, and postfixation in osmium tetroxide at 2%
for one hour, the tissue was dehydrated in ascending
concentrations of ethanol and embedded in epoxy
resin (Epon). One-micron sections were mounted on
glass slides and coated with emulsion (Ilford KS),
diluted with an equal volume of distilled water. This
procedure gives an emulsion coat of approximately
2 thickness. After being left to dry in the vertical
position overnight, slides were exposed at room
temperature over phosphorous pentoxide, for six to
eight weeks. After development in Kodak D 19, rapid
rinsing in distilled water and ten minutes' fixation in
30% sodium hyposulfite solution, the sections were
stained with 0.5% toluidine blue in 1% sodium borate
solution and examined by light microscopy.
Experimental protocol. Group I: Rats receiving 3H-
angiotensin alone (24 rats). Animals of this group
received different doses of tritiated angiotensin II and
the kidney was fixed at various times after the injec-
tion. In 12 rats, kidneys were fixed two minutes after
3H-angiotensin II administration. Of these, nine
received 100 ng, two received 25 ng and one received
1 ng of labelled hormone. A further six rats received
100 ng of 3H-angiotensin II and kidneys of two rats
were fixed at each of the following times after the in-
jection: 1, 5 and 30 mm.
In order to see whether the state of sodium balance
can affect the results, three rats were maintained on a
low salt diet (boiled, unsalted rice; fresh vegetables;
distilled water to drink) and three on a high salt diet
(normal laboratory chow; NaCl, 0.9%, to drink) for
four days. These six rats then received 100 ng of 3H-
angiotensin II and kidneys were fixed after two
minutes. In addition, some ultrathin sections were cut
from blocks of kidney taken two minutes after injec-
tions of 100 ng of 3H-angiotensin II and these were
prepared for electron microscopic autoradiography
according to the method of Larra and Droz [9].
Group II: Rats receiving other compounds together
with 3H-angiotensin II (12 rats). In order to test the
specificity of the reaction with 3H-angiotensin II
alone, three rats were given l0sg of the lie8-
angiotensin II, a competitive antagonist of
angiotensin II in vivo and in vitro [10], one minute
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prior to the 100 ng of 3H-angiotensin II. This dose of
1le8-angiotensin II had a pressor activity equivalent to
that of 60 ng of angiotensin II and blocked by 90%
the pressor response to the 100 ng of 3H-angiotensin
II given one minute later. Kidneys were fixed two
minutes after the tritiated hormone administration.
As an additional test for specificity, an isotopic
dilution was performed. Six rats received 10kg of
nonradioactive angiotensin II (Hypertensin CIBA)
together with the 100 ng of 3H-angiotensin. In four
rats the kidneys were fixed after two minutes and in
two rats after five minutes. Any autoradiographic
reaction which is specific for angiotensin II should
thus be greatly diminished or abolished by this
method since saturability is one of the criteria for
specific binding. In order to eliminate the possibility
that the results found after cold angiotensin II and
Ile8-angiotensin II administration were due to a non-
specific vasoconstrictor effect, three rats received
l0tg of noradrenaline (L-noradrenaline bitartrate,
Sigma) together with 100 ng of 3H-angiotensin II and
kidneys of two rats were fixed after two minutes and
those of the remaining rat after five minutes. Any
autoradiographic reaction which is eliminated by this
dose of noradrenaline would thus not be specific for
angiotensin II but would depend upon the extent of
renal vasoconstriction and pressure-flow relation-
ships within the kidney at the time of arrival of the
tritiated hormone.
Group 1H. Rats receiving radioactive compounds
other than 3H-angiotensin II (six rats). Since the renal
radioactivity after 3H-angiotensin II administration
may represent either angiotensin II or a metabolite,
we decided to compare results with those seen after
3H-tyrosine administration. Four rats received 100 ng
of 3H-tyrosine. The kidneys of three rats were fixed
after two minutes and those of the remaining rat after
five minutes. This experiment would also serve as a
control for any unspecific effect due to nonuniform
washout by perfusing fixative.
The only tritiated metabolite of angiotensin II at
our disposition was the 2-8-angiotensin II-
heptapeptide. Two rats received 400 ng of this com-
pound and the kidneys were fixed after two minutes.
The dose of 400 ng was chosen in view of the
relatively low specific activity of this compound (7
Ci/mmole).
Control tissues. Two rats underwent whole body
perfusion of 2.3% buffered glutaraldehyde after injec-
tion of 100 ng of 3H-angiotensin II in order to
prepare the liver, heart and lung for autoradiography
as control tissues. Fixation was performed by
retrograde perfusion via the abdominal aorta after
cardiac arrest induced by i.v. administration of
procaine (1%, 2 ml). Autoradiographs were prepared
of these tissues by the same method as for the kidney.
Quantification. Two methods of quantification
were employed. In the first series of experiments per-
formed, an attempt was made to quantify the dis-
tribution of radioactivity in each renal cell type. This
was achieved by counting the number of silver grains
present in a field of l00t2 after placing the nucleus of
each cell in the center of this field. Cells were chosen
at random from six rats whose kidneys were fixed two
minutes after receiving 100 ng of 3H-angiotensin II,
and from two rats that received the 11e8-angiotensin H
prior to tritiated angiotensin administration.
Background was defined as the number of grains per
lOOj2 in an area of emulsion with no underlying tis-
sue, eg., tubular lumen. All cells of the glomerular
tuft which were not obviously podocytes or en-
dothelial cells were classed as mesangial cells.
Mesangial cells are defined as lying on the luminal
side of the basement membrane, are limited by en-
dothelial cells and the basement membrane and thus
have an intercapillary localization, with no direct
contact with the capillary lumen [11].
In subsequent experiments, since tubular and
vascular radioactivity was negligible, a more simple
method of quantification was employed. The total
number of silver grains per glomerulus together with
the total number of silver grains lying over the
mesangium in each glomerulus were counted.
Glomeruli were chosen at random from those which
were technically satisfactory in the different experi-
ments. Quantitative comparisons of glomerular
radioactivity can only be made between rats having
received the same batch of 3H-angiotensin II, because
of the different specific activities of the different
batches. For this reason a direct comparison cannot
be made between the different histograms presented
in the Results, but can be made only between the
columns within each histogram. Comments on the
difficulties involved in quantification are given in the
Discussion.
Results
Group I. Rats receiving 3H-angiotensin alone. In
kidneys of the nine rats that received 100 ng of 3H-
angiotensin II, and which were fixed two minutes
later, there was without exception a net concentration
of radioactivity in the glomeruli as compared with
blood vessels, tubules and interstitium (Fig. 1). No
reaction was found over the macula densa or the
lacis. Within the glomerulus, the highest concentra-
tion of silver grains was localized over the cytoplasm
of the mesangial cells (Fig. 1). Quantification of
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radioactivity in the different cell types taken at ran-
dom from glomeruli of six of these rats confirmed this
mesangial distribution (Table 1). No significant
difference was found in the mesangial radioactivity of
glomeruli localized in superficial and deep cortex in
the one rat considered (Fig. 2). Electron microscopic
autoradiography confirmed this mesangial con-
centration of radioactivity (Fig. 3d). The time-course
of the reaction at 1, 2, 5 and 30 mm is represented in
Fig. 4. It can be seen that mesangial radioactivity is
higher at 2 and 5 mm than at 1 mm but is con-
siderably diminished at 30 mm. In fact, at 30 mm, the
percentage of nonmesangial glomerular radioactivity
Fig. 1. Autoradiograph of rat kidney two
minutes after intraaortic administration of
/00 ng of 3H-angiotensin II (X820). Most
silver grains overlie mesangial cells (ver-
tical arrows) whereas scarce grains are
found over podocytes (p) and endothelial
cells (e). Proximal (PT) and distal (DT)
convoluted tubules and arterioles (A) are
almost free of reaction.
is significantly higher than at the earlier times. Fig. 5a
shows an autoradiograph of a renal glomerulus five
minutes after a dose of 100 ng of 3H-angiotensin II.
At two minutes after a dose of 25 ng of 3H-
angiotensin II, a very low mesangial concentration of
radioactivity was seen (Fig. 4). No reaction was
detected after a dose of I ng of 3H-angiotensin II.
There was a net difference in glomerular radioactivity
between rats maintained on a salt-rich diet and those
on a low salt diet. Two minutes after an injection of
100 ng of 3H-angiotensin II (Fig. 6), it can be seen
that mesangial radioactivity is considerably lower in
the latter case.
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Group II. Rats receiving other compounds together
with 3H-angiotensin II. In kidneys of rats which
received 11e8-angiotensin II, the mesangial reaction
was greatly reduced or abolished (Fig. 2, Fig. 5b and
Table 1). The same result was seen after simultaneous
administration of nonradioactive angiotensin II and
3H-angiotensin II at two and five minutes after the in-
jection (Fig. 3a and Fig. 4). On the other hand, after
simultaneous administration of noradrenaline and
3H-angiotensin II, mesangial radioactivity at two
minutes after injection did not differ significantly
from that of glomeruli for rats having received the
same dose of 3H-angiotensin II alone (Figs 3b and 4).
An identical result was found five minutes after the
injection.
Group III: Rats receiving radioactive compounds
other than 3H-angiotensin II. Very few silver grains
were seen anywhere in the kidney after 3H-tyrosine
administration (Fig. 4) but the 3H-heptapeptide gave
the same localization as the 3H-angiotensin II (Fig.
3c). No attempt at quantification was made in the
case of the 3H-heptapeptide because of the very
different specific activity of this compound compared
with that of the 3H-angiotensin and the 3H-tyrosine.
Group IV. Although scattered grains were present,
there was no evidence of concentration of silver
grains over any single cell type in the heart, lung or
liver.
Discussion
Cell type
Silver grains
/ l00L2, N
Cells counted,
N
Glomerular mesangial cells 3.2 0.2 247
Glomerular endothelial cells 0.7 0.1 186
Podocytes 0.7 0.1 251
Arteriolar smooth muscle cells 0.3 0.1 84
Proximal tubule epithelial cells 0.7 0.1 240
Distal tubule epithelial cells 0.4 0.1 230
Interstitial cells 0.4 0.1 191
Macula densa cells 0.2 0.1 36
Mesangial cells after Ile'-angio-
tensin II administration 0.5 0.1 75
Background 0.3 0.1
method of quantification of silver grains over whole
glomerular cross-sections requires that the range of
cross-sectional diameters of glomeruli in the different
groups be comparable. Since glomeruli were chosen
at random, this should have been the case except
when the number of glomeruli available for counting
was small.
However, this lack of an ideal method of quantifi-
cation does not modify the quality of the principal ex-
perimental results, which are evident on examination
Glutaraldehyde, the fixative used in these experi-
ments, is capable of reinforcing bonds between the
tritiated angiotensin II and the amino groups of any
protein molecule [12]. Thus, both artefactual and
specific relationships between molecules may be rein-
forced by this method of fixation. The reproducibility
of our results, together with the various tests for
specificity used, show that the phenomenon we are
studying is not a fixation artefact.
There are certain problems involved in the
methods of quantification employed. First, the iden-
tification of mesangial cells in light microscopy is not
always easy and some confusion with endothelial
cells may arise. Depending on the plane of section,
some endothelial cells may appear not to be in direct
contact with the capillary lumen and, hence, classified
wrongly as mesangial cells. However, the experiments
performed by electron microscopy confirmed that
radioactivity was principally concentrated in
mesangial cells. Second, the method of quantification
of silver grains over each renal cell type does not take
into account different nuclear/cytoplasmic ratios,
and so errors may be introduced here. Third, the
Table 1. Concentration of radioactivity in different renal cell
types 2 mm after intraaortic administration of 100 ng of 3H-
angiotensin II
311-AII
100 ng
2 mm
(N= 1)
Ile8—AII
+ 3H-AII
100 ng
2 mm
(N= 6)
Outer
cortex
3H-AII
100 ng
2 mm
(N= 12)
Inner
cortex
3i-i-AII
100 ng
2 mm
(N =5)
Fig. 2. Histogram showing mean number of silver grains per
glomerulus SEM. Column 1: Two minutes after 100 ng of 3H-
angiotensin II. Column 2: Two minutes after 100 ng of 3H-
angiotensin II preceded by 10 g of 11e8-angiotensin II. Columns 3
and 4 represent outer and inner cortex, respectively, taken from the
same rat two minutes after 100 ng of 3H-angiotensin II. N =
number of glomeruli counted. For each of columns 1 and 2,
glomeruli were selected at random from two rats.
100
so
Grains tying0 over mesangium
Extra mesangial
grains
U
1 2 3 4
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Fig. 3. Au:oradiographs of rat kidney glomeruli. a, Two minutes after the simultaneous administration of 10 ig of nonlabelled angiotensin II
and 100 ng of 3H-angiotensin II (X620). Note the absence of mesangial reaction. b, Two minutes after the simultaneous administration of 10
g of noradrenaline and 100 ng of 3H-angiotensin II. Note the mesangial radioactivity, and absence of reaction over the arteriole (X620). c,
Two minutes after the administration of 100 ng of 3H-2-8-heptapeptide. Radioactivity is localized only over the mesangium. Arteriole and
distal tubule are free of reaction (X620). d, An electron microscopic autoradiograph showing silver grains over the cytoplasm of a glomerular
mesangial cell, two minutes after the administration of 100 ng of 3H-angiotensin II (X 16,000).
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of the autoradiographs. The quantification only
provides supplementary evidence.
The dose of 3H-angiotensin 11(100 ng) employed in
these experiments is rather large and although we
cannot know the local concentration at the level of
the kidney, it is likely to be well above the
physiological range. We were obliged to use such a
pharmacological dose because we were limited by the
specific activity of the labelled hormone. At a dose of
25 ng, the autoradiographic reaction was very small
(Fig. 5) and with 1 ng no reaction was detectable.
Despite this inconvenience of a high dose, we still
preferred to use a tritiated hormone, rather than its
radioactive iodinated counterpart, since the
biological activity and steric properties of this latter
compound are considerably altered by the introduc-
tion of an iodine atom.
The finding of radioactivity localized in the
glomerular mesangial cells and not in the renal
arteriolar walls is unexpected. Whether such a reac-
tion indicates a physiological role of angiotensin II at
the level of the mesangial cells cannot be known from
these experiments, but there is, however, certain
evidence that the reaction is specific for this hormone
and therefore may have some functional significance.
The specificity of the reaction for angiotensin II is
demonstrated by several observations: 1) A dose of
competitive inhibitor lle8-angiotensin II, large
enough to block by 90% the blood pressure response
to the 100 ng of 3H-angiotensin II when given one
minute before, greatly reduced or abolished the
mesangial concentration of radioactivity. 2) A large
dose of nonradioactive angiotensin II given
simultaneously with the 3H-angiotensin II had a
similar inhibitory effect. This dose of nonradioactive
hormone had a considerable renal vasoconstrictor
effect and may have simply diminished the access of
radioactivity to the kidney. However, the fact that
another vasoconstrictor, noradrenaline, did not
significantly diminish the mesangial concentration of
radioactivity suggests that the unlabelled angiotensin
II did act in competition with the 3H-angiotensin II at
the mesangial cells, indicating saturability of the
binding site. Despite the fact that angiotensin II and
noradrenaline are not equipressor, it is probable that
at the doses employed, maximal renal vasoconstric-
tion was attained in both cases, and that the
differences between the effects of cold angiotensin II
and noradrenaline on the mesangial reaction do not
depend on pressure-flow relationships within the
kidney. 3) The 2-8-heptapeptide is the first metabolite
of angiotensin II produced after action of aminopep-
tidase A in the kidney [13, 14]. The tritiated form of
this heptapeptide gave the same localization in the
kidney as 3H-angiotensin II, but since this analogue
has 60% of the biological activity of the octapeptide
angiotensin II, and displaces 8H-angiotensin II from
its receptors in rabbit aorta membranes by 81% [15,
16], this result is not surprising.
The mesangial radioactivity may theoretically
represent 3H-angiotensin II or any tyrosine-
containing metabolite down to 3H-tyrosine. The
arguments for specificity suggest that the radioactive
molecule which interacts with the mesangial cells is
intact angiotensin II. It appears unlikely that it repre-
sents 3H-tyrosine or small tyrosine-containing frag-
ments for two reasons: 1) 3H-tyrosine did not give
this localization and 2) the short time between injec-
tion and fixation in some experiments (one minute) is
not compatible with an extensive degradation of the
hormone.
However, we cannot exclude the possibility that
the C-terminal hepta-, hexa- and pentapeptides are
responsible for the reaction since these can enter into
competition with angiotensin II, at least in binding
sites in rabbit aortic membranes [16]. It is evident
that once the radioactive molecule has interacted
with the mesangial cell, it may be degraded within the
cell; and so at longer times after the injection it is
quite probable that the radioactivity represents small
0
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0
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0I-
.0
z 2 mm 30 mm
(N=23) (N=19)
1mm 5mm
(N= 17) (N= 18)
3H-AII 10ng
3H-Tyr
100 ng
2 mm
(N= 22)
3H—AII, 100 ng 3H—ATI
+AII 25 ng
2mm 2mm
(N=16) (N=14)
Fig. 4. Histogram showing mean number of silver grains per
glomerulus SEM. Columns 1-4: at one, two, five and thirty minutes
after injection of 100 ng of 3H-angiotensin II. Column 5: two
minutes after injection of 10 sg of cold angiotensin II plus 100 ng
of 3H-angiotensin II. Column 6: two minutes after injection of 10sg
of noradrenaline plus 100 ng of 3H-angiotensin II. Column 7: two
minutes after injection of 100 ng of 3H-tyrosine. Column 8: two
minutes after injection of 25 ng of 3H-angiotensin II. N = number
of glomeruli counted. For each column, glomeruli were selected at
random from two rats.
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3H-AII 3H-AII
100 ng 2 mm 100 ng 2 mm
(N=32) (N=34)
Fig. 6. Histogram showing mean number of silver grains per
glomerulus SEM. Column 1: salt-loaded rats. Column 2: salt-
deprived rats, both two minutes after injection of 100 ng of 3H-
angiotensin II. N = number of glomeruli counted. For each
column, glomeruli were selected at random from three rats.
tyrosine-containing metabolites which have not yet
been mobilized.
The fact that in our experiments the mesangial con-
centration of radioactivity is affected by the sodium
balance of the rat is interesting, since angiotensin is a
hormone directly concerned with salt and water
homeostases. It should be noted here that the studies
of Brunner et al [17] on vascular receptors of
angiotensin II suggest a decreased affinity of these
receptors for the hormone under conditions of
sodium loss. One may also explain this result by con-
sidering the variations in levels of endogenous
angiotensin II induced by changes in sodium balance.
With low dietary sodium intake, endogenous
angiotensin II concentrations are high, and mesangial
sites may be occupied to a great extent by the en-
dogenous hormone, thus reducing those free for the
exogenous tritiated angiotensin II. This situation
would be reversed under conditions of sodium
loading, leaving a higher proportion of sites free for
the exogenous tritiated hormone.
Although our study provides evidence for a specific
interaction of angiotensin II with the mesangial cells,
the significance of this finding is unknown. There are
two possible explanations: I) Since mesangial cells
are known to be phagocytic [18] and may form part
of the reticulo-endothelial system [19], the 3H-
angiotensin II could be specifically bound to a cir-
culating protein macromolecule [20] which is then
phagocytosed by the mesangium. However, this ex-
planation is unlikely since no reaction was seen in the
Kuppfer cells of the liver or the phagocytic cells of
the lungs. 2) The 3H-angiotensin II may interact
directly with a specific site within the mesangial cells.
This site may be either enzymatic, the mesangial cells
representing a preferential site for the degradation of
the hormone, or could be associated with some un-
known physiological function of angiotensin II in the
mesangium.
The exact nature and function of the mesangial
cells is unknown [11]. They probably have both
secretory and phagocytic functions [19] which could
conceivably be modified by administration of
angiotensin II. These cells are also in direct contact
with the lacis and hence the juxtaglomerular cells [21]
and could perhaps be involved in the feedback con-
trol of renin release, or even in the control of
glomerular filtration rate via renin release [7].
Finally, mesangial cells have been reported to con-
tain contractile elements [22-24] and have been im-
plicated in glomerular contraction [25]. Angiotensin
II has been shown by scanning electron microscopy
to induce changes in glomerular shape [26] and also
by light microscopy to reduce the diameter of isolated
glomeruli [27]. Angiotensin II could thus possibly ex-
ert its regulatory effect on glomerular filtration rate
partially or completely by contraction of the
mesangium. A recent study has produced evidence
for the presence of specific binding sites for iodinated
angiotensin II in isolated rat glomeruli [27].
Although we have evidence for a specific reaction
of angiotensin II with the renal mesangial cells, the
limitations of the method are such that the interac-
tion of angiotensin II with its vascular receptors is
not visualized. We cannot, therefore, rule out the
possibility of angiotensin interaction with other renal
structures.
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Fig. 5. a, Autoradiograph of rat kidney five minutes after intraaortic administration of 100 ng of 3H-angiotensin 11(X) 100). Note mesangial
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